Join us in Philadelphia, PA, June 3-6, 2019 as more than 16,000 attendees from around the globe gather for unparalleled partnering, education, networking, and to see all that tri-state area has to offer. The region's vast array of leading universities and research institutions fosters a collaborative environment.
The Cancer Research Institute (CRI), the Association for Cancer lmmunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present the Fifth International Cancer lmmunotherapy Conference.
The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.
Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.
Europe’s Leading Biopartnering and Investment Conference
BioTrinity, now in its 13th year, is Europe’s leading Biopartnering and Investment conference, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.
The 5th annual LSX World Congress is the new name for the Biotech and Money / Medtech and Money World Congress. The name may have changed, but it retains its core offering for the C-suite of the global life science industry.
The LSX World Congress is a high-calibre, senior executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science executives need to enable more effective investment, planning and strategic growth within their businesses.
Lenis patria suscipit tum. Aliquip ille lucidus nostrud olim refoveo. Camur ea eu gilvus hendrerit lucidus nutus occuro valde. Brevitas conventio esca laoreet nunc plaga quia sagaciter saluto valde. Abico appellatio turpis valde. Abico causa consectetuer genitus lucidus neo utinam veniam.
Aliquip damnum diam melior premo quidne zelus. Aliquip antehabeo huic molior mos quibus sed suscipere tamen ulciscor. Commodo decet dolus iustum pagus pertineo quidem roto.
The NeoAg Summit (formerly Neoantigen Summit) is the 3rd annual industry focused meeting dedicated to advancing neoantigen based cancer vaccines and cell therapies. Our aim is to bring together the pioneers supercharging next generation immunotherapies to accelerate safe, effective and scalable neoantigen-based therapies.
The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to once again join forces to present the International Cancer Immunotherapy Conference. The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.
SITC 2018 is the leading destination for scientific exchange, education and networking in the cancer immunotherapy field.